[ Price : $8.95]
CDER director Patrizia Cavazzoni unexpectedly announces her early retirement effective two days before the new Trump administratio...[ Price : $8.95]
Over 18,000 appalled physicians sign an open letter urging the U.S. Senate to reject the nomination of Robert F. Kennedy Jr. to se...[ Price : $8.95]
FDA accepts for review a Fortress Biotech NDA for CUTX-101 (copper histidinate) for treating Menkes disease.[ Price : $8.95]
Tenpoint Therapeutics reports positive topline results from BRIO-II, the companys second Phase 3 pivotal trial evaluating Brimocho...[ Price : $8.95]
FDA clears a CapsoVision 510(k) for its CapsoCam Plus capsule endoscopy system for remote ingestion.[ Price : $8.95]
Pfizer reports positive topline results from its pivotal Phase 3 CREST trial evaluating sasanlimab for combination use with Bacill...[ Price : $8.95]
Federal Register notice: FDA announces that a priority review voucher was used with the agencys 12/20/2024 approval of Vertex Phar...[ Price : $8.95]
FDA says it will review an Agios sNDA for a new Pyrukynd indication and sets a 9/7 PDUFA action date.